Crossmark

Evaluation of the Therapeutic Effectiveness of a Composite Agent in the Treatment of Radiation–Thermal Damage

Published Online: 2025-03-17

Published Print: 2024-12

Authors

Gaynutdinov, T. R. https://orcid.org/0000-0003-3832-883X
Vagin, K. N. https://orcid.org/0000-0003-4396-614X
Nizamov, R. N. https://orcid.org/0000-0002-8595-0800
License Information

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-12-01
More Information

Article History

Received: 26 January 2023

Revised: 17 August 2023

Accepted: 29 May 2024

First Online: 17 March 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: All procedures involving model animals were carried out in accordance with Good Laboratory Practice and Directive 2010/63/EU of the European Parliament and of the Council (2010) on the protection of animals used for scientific purposes. The study was approved by the Local Ethics Committee of the Federal Center for Toxicological, Radiation, and Biological Safety (protocol no. 11 dated February 28, 2023).

: The authors of this work declare that they have no conflicts of interest.

Document is current